Ask a Question

Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others

* Required field

Your Email Address *

Please enter a valid email address.

Choose a Topic *

Tell us your question and any additional information *

Please enter all required fields.

Please Log In/Join Now first, and then use this function!

Find a Clinical Trial

Covid-19 (Coronavirus) Message for Patients

Note: As a result of the current COVID-19 (Coronavirus) restrictions, research sites may incorrectly be listed as recruiting or be delayed in responding to patient inquiries due to possible closures. It is suggested that interested patients awaiting a response or current study patients can contact the research site at the phone number provided to ask about study status or confirm scheduled appointments before arriving. Read more about BMS's response to COVID-19 at www.BMS.com.

Researching Lung Cancer

Lung cancer starts when cells of the lung become abnormal and begin to grow out of control

Lung Cancer Clinical Trials

We are investigating experimental medications for both Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC)

Non-small cell lung cancer (NSCLC)  accounts for about 85–90% of Lung Cancer diagnoses, while Small cell lung cancer (SCLC) is composed of 10-15% of Lung Cancer diagnoses. These two types of cancer differ in how they grow and how they spread.

Answer a few questions below to see if there are clinical trials that might be right for you. 

Thank you for Considering a Clinical Trial

Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).

Here are some options for you to find more information:

Browse the trials available on your own and Click on View Trial Details for more information, including locations that are recruiting patients.
- or -
Let us help you find a trial: Pre-Screen Now and answer a few questions to determine if there is a trial that might be right for you.

Non-small Cell Lung Cancer (Advanced or Recurrent – Stages 3B and 4)

CA209-227

Recruiting

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

This clinical trial is no longer recruiting patients.

View Trial Detail

CA017-003

Recruiting

An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

View Trial Detail

CA209-592

Recruiting

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

View Trial Detail

CA209-8KX

Recruiting

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

Recruitment is currently paused for this study.

View Trial Detail

CA209-73L

Recruiting

A Study of Nivolumab and Ipilimumab in Untreated Patients With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

View Trial Detail

CA224-104

Not Yet Recruiting

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

View Trial Detail

Non-small Cell Lung Cancer (Early Stage – Stages 1, 2 and 3A)

CA224-048

Recruiting

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

View Trial Detail

CA209-77T

Recruiting

A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer

View Trial Detail

CA209-76U

Recruiting

A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types

View Trial Detail

Small Cell Lung Cancer

CA209-848

Recruiting

A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

View Trial Detail

Get updates on lung cancer clinical trials

Get notified when new studies open that might be right for you

What are you thankful for?

"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...

Silver Linings, Breast Cancer - Survivor

View Story

"I am thankful that I had friends & family to lean on – I don’t like being vulnerable, but being so was freeing in the end." ...

Silver Linings, Breast Cancer - Survivor

View Story

"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"

Larry and Nancy, Melanoma

View Story

"I noticed a red spot on my shoulder and didn't think too much about it, but after a few more days it didn't change. Nancy recommended that I probably ought to get it checked"

Larry and Nancy, Melanoma

View Story

"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"

Lucy, Rheumatoid Arthritis

View Story

"They want you to be as safe as possible. So as soon as they notice something is off, they will tell you. And you have the option of saying, 'OK, I'm out.'"

Lucy, Rheumatoid Arthritis

View Story

"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"

Tolley, Melanoma

View Story

"The medical oncologist did lay out exactly what was going to happen if I did go through this clinical trial, so there weren't any surprises"

Tolley, Melanoma

View Story

All Stories

Explore Lung Cancer Resources

Lung Cancer by the Numbers

Lung cancer has been the most common cancer in the world for several decades, and despite advancements in treatment, has resulted in more deaths than any other cancer.

Learn More

SELECTED SUPPORT ORGANIZATIONS AND DISEASE INFORMATION

Bristol Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.

American Cancer Society Dedicated to helping people who face cancer

Lung Cancer Overview National Cancer Institute Condition Overview

We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information

Have questions? Live support is available 24/7 - Call 855-907-3286 or email clinical.trials@bms.com

Have questions? Live support is available 24/7 -

Call 855-907-3286 or email clinical.trials@bms.com